Assignee

Xencor, Inc.

Patents = 214

Trademarks = 7

Forward Citations = 3,713

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

125 inventors (with patents filed for the assignee):

Xencor, Inc. is a biopharmaceutical company specializing in the development of engineered monoclonal antibodies for the treatment of severe diseases. Their unique technology platform enables the creation of antibody drugs with enhanced therapeutic properties, improving patient outcomes. Xencor's focus areas include oncology, autoimmune disorders, and allergic diseases. Through their innovative approach, Xencor aims to transform the lives of patients by advancing the understanding and application of monoclonal antibody therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com